NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

National Rapid TLC: Testing and Linkage to Care

Not Yet RecruitingNA

Sponsor: Unity Health Toronto

Conditions: HIV, Chlamydia, Gonorrhea, HCV, HPV

Interventions: Xpert® HIV-1 Qual XC

Countries: Canada

The goal of this cross-sectional study is to learn if the GeneXpert system is a practical system for HIV and STBBI testing in community-based organizations and health clinics. The study involves a clinical trial to learn if the HIV-1 Qual XC test works to identify HIV in near-patient settings. The main questions it aims to answer are to create a near-patient testing model for testing and treating patients in a single visit, and to learn if the HIV-1 Qual XC test works to accurately detect HIV in patients. Patients who come to study sites to ask for HIV or STBBI testing will be given the option to participate in the study. Those who agree with provide samples for the tests of their choice and answer survey questions before and after their tests are completed. Those who participate in the clinical trial will have a blood sample sent to provincial labs to compare the results to the HIV -1 Qual XC test. Follow-up visits will be done at 1,3 and 6 months to see if patients completed treatment and/or remained connected to care.

Eligibility overview

Sex: ALL

Age: 16 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Individuals accessing STBBI testing at specific locations who are ≥ 16 years of age
* Able to provide informed consent.

Exclusion Criteria:

* Unable to provide signed informed consent (e.g., intoxicated)
* In the opinion of the site PI /study operator, the participant is unable to complete the study elements.
* Participants who have previously enrolled in the study.

Locations (2)

Toronto, Ontario, Canada
Toronto, Ontario, Canada